Related Experiment Video
Updated: Mar 25, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.4K
Management of obesity.
George A Bray1, Gema Frühbeck2, Donna H Ryan1
1Pennington Biomedical Research Center/LSU, Baton Rouge, LA, USA.
Lancet (London, England)
|February 13, 2016
Summary
Effective obesity management requires lifestyle changes like diet and exercise. For some, medication or bariatric surgery may be necessary to achieve significant weight loss and improve health outcomes.
Area of Science:
- Obesity Medicine
- Metabolic Health
- Bariatric Science
Background:
- Obesity is a complex condition with multiple contributing factors to weight gain.
- Weight loss offers significant health benefits, making effective management crucial.
- Lifestyle interventions are the cornerstone of weight loss strategies.
Purpose of the Study:
- To outline a comprehensive, modern approach to obesity management.
- To detail the components of successful lifestyle interventions for weight loss.
- To review pharmacological and surgical options for individuals struggling with weight management.
Main Methods:
- Emphasis on high-quality, sustainable dietary changes.
- Prescription of exercise detailing frequency, intensity, type, and duration (minimum 150 minutes/week moderate activity).
- Consideration of medication management and approved weight management drugs.
- Evaluation of surgical interventions for severe obesity.
Main Results:
- Lifestyle changes, including diet and exercise, are foundational for weight loss.
- Medication-assisted weight management and surgical options can yield significant health improvements.
- Approved medications include orlistat, naltrexone/bupropion, and liraglutide.
- Surgical procedures like gastric banding, sleeve gastrectomy, and Roux-en Y gastric bypass reduce mortality in severe obesity.
Conclusions:
- A multifactorial approach integrating lifestyle, medication, and surgery is essential for effective obesity treatment.
- Personalized strategies are key to achieving sustainable weight loss and improving patient health.
- Modern obesity management acknowledges the complexity and offers diverse therapeutic options.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
1.4K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.4K
01:24Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
368
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
368
01:21Drug Dosing: Obese Patients
335
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
335
01:26Atherosclerosis III: Management
577
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
577
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
279
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
279